Skip to content
GenoLensGenoLens

PPP1CB

Chr 2p23.2

protein phosphatase 1 catalytic subunit beta

Aliases:
PP1Cbeta, PPP1CD, PP1Cdelta, PP1B, PP-1B
MANE:
ENST00000395366.3

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Intellectual disability

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Monogenic short stature

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Paediatric or syndromic cardiomyopathy

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Pigmentary skin disorders

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Primary lymphoedema

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • RASopathies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

+3 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • Noonan syndrome-like disorder with loose anagen hair 2

    0.74
  • Noonan syndrome-like disorder with loose anagen hair

    0.72
  • Noonan syndrome

    0.58
  • neurodegenerative disease

    0.56
  • RASopathy

    0.52
  • Abnormality of the cardiovascular system

    0.50
  • autoimmune disorder of central nervous system

    0.45
  • Abnormality of the skeletal system

    0.39
  • hereditary disease

    0.37
  • carcinoma of esophagus

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Serine/threonine-protein phosphatase PP1-beta catalytic subunit

Protein phosphatase that associates with over 200 regulatory proteins to form highly specific holoenzymes which dephosphorylate hundreds of biological targets. Protein phosphatase (PP1) is essential for cell division, it participates in the regulation of glycogen metabolism, muscle contractility and protein synthesis. Involved in regulation of ionic conductances and long-term synaptic plasticity. Component of the PTW/PP1 phosphatase complex, which plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. In balance with CSNK1D and CSNK1E, determines the circadian period length, through the regulation of the speed and rhythmicity of PER1 and PER2 phosphorylation. May dephosphorylate CSNK1D and CSNK1E. Dephosphorylates the 'Ser-418' residue of FOXP3 in regulatory T-cells (Treg) from patients with rheumatoid arthritis, thereby inactivating FOXP3 and rendering Treg cells functionally defective (PubMed:23396208). Core component of the SHOC2-MRAS-PP1c (SMP) holophosphatase complex that regulates the MAPK pathway activation (PubMed:35768504, PubMed:35831509, PubMed:36175670). The SMP complex specifically dephosphorylates the inhibitory phosphorylation at 'Ser-259' of RAF1 kinase, 'Ser-365' of BRAF kinase and 'Ser-214' of ARAF kinase, stimulating their kinase activities (PubMed:35768504, PubMed:35831509, PubMed:36175670). The SMP complex enhances the dephosphorylation activity and substrate specificity of PP1c (PubMed:35768504, PubMed:36175670)

Curated MONDO disease pages that list PPP1CB among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.